Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SB-221420 in development for stroke

May 17, 1996

SB-238592: Antiinflammatory neuroprotectant in clinical phase

May 17, 1996

Seven new uses for raloxifene appear in patent literature

May 17, 1996

NMDA antagonists reported by Pfizer

May 17, 1996

Valproate effective in dementia patients

May 17, 1996

Increased platelet aggregation in AD patients

May 17, 1996

Sankyo claims allosteric muscarinic effectors for AD

May 17, 1996

GP-3269 on track for clinical testing

May 17, 1996

SB-204269 in phase I for epilepsy

May 17, 1996

Ketoconazole: Potential treatment for depression?

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 4, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
First atlas of the endometrium with polycystic ovary syndrome
BioWorld Science
Although the causes of polycystic ovary syndrome (PCOS) are unclear, researchers know this condition leads to endometrial dysfunction in women who have hormonal...
Another rebound as Sangamo inks $1.4B capsid deal with Lilly
BioWorld
Sangamo Therapeutics Inc. is adding a much-needed $18 million up-front payment in a neurology-focused deal with Eli Lilly and Co. that could bring up to an...